The importance of p53′s anti-cancer functions in preventing tumor progression is exceedingly highlighted by the high frequency of its functional aberration in human cancers that either harbor mutations in its gene (over 50%) or highly express its oncogenic inhibitor molecules, such as MDM2 or MDMX. The gene discussed is MDM2; the disease is neoplasm.